These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24273178)

  • 1. Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--Alaska, 2008-2012.
    Gounder PP; Bruce MG; Bruden DJ; Singleton RJ; Rudolph K; Hurlburt DA; Hennessy TW; Wenger J
    J Infect Dis; 2014 Apr; 209(8):1251-8. PubMed ID: 24273178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of pneumococcal nasopharyngeal colonization and serotypes circulating in Cameroonian children after the 13-valent pneumococcal conjugate vaccine introduction.
    Njuma Libwea J; Gröndahl-Yli-Hannuksela K; Kobela M; Toropainen M; Nyholm O; Ndombo PK; Koulla-Shiro S; Nohynek H; Nuorti JP; Vuopio J; Palmu AA
    Int J Infect Dis; 2020 Sep; 98():113-120. PubMed ID: 32562849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual colonization by vaccine serotypes in rural South Africa four years following initiation of pneumococcal conjugate vaccine immunization.
    Madhi SA; Nzenze SA; Nunes MC; Chinyanganya L; Van Niekerk N; Kahn K; Twine R; De Gouveia L; Von Gottberg A; Shiri T
    Expert Rev Vaccines; 2020 Apr; 19(4):383-393. PubMed ID: 32237932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age.
    Nunes MC; Jones SA; Groome MJ; Kuwanda L; Van Niekerk N; von Gottberg A; de Gouveia L; Adrian PV; Madhi SA
    Vaccine; 2015 Jan; 33(5):628-34. PubMed ID: 25541213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.
    Dagan R; Patterson S; Juergens C; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
    Clin Infect Dis; 2013 Oct; 57(7):952-62. PubMed ID: 23804191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage Rates of Streptococcus pneumoniae in a Rural Community in the Dominican Republic.
    Dunn MG; Lessa FC; Sánchez J; Cordero R; Feris-Iglesias J; Cedano D; Carvalho MDG; Fernández J; Feemster KA
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S237-S247. PubMed ID: 34469551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Pneumococcal Conjugate Vaccine and Antibiotic Use on Nasopharyngeal Colonization by Antibiotic Nonsusceptible Streptococcus pneumoniae, Alaska, 2000[FIGURE DASH]2010.
    Gounder PP; Brewster M; Bruce MG; Bruden DJ; Rudolph K; Hurlburt DA; Hennessy TW
    Pediatr Infect Dis J; 2015 Nov; 34(11):1223-9. PubMed ID: 26226443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.
    Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C
    Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine.
    Satzke C; Dunne EM; Choummanivong M; Ortika BD; Neal EFG; Pell CL; Nation ML; Fox KK; Nguyen CD; Gould KA; Hinds J; Chanthongthip A; Xeuatvongsa A; Mulholland EK; Sychareun V; Russell FM
    Vaccine; 2019 Jan; 37(2):296-305. PubMed ID: 30502068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae.
    Dagan R; Juergens C; Trammel J; Patterson S; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
    J Infect Dis; 2015 Apr; 211(7):1144-53. PubMed ID: 25355940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-specific Effectiveness of 7- and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-serotype Streptococcus pneumoniae Colonization in Children.
    Lewnard JA; Givon-Lavi N; Dagan R
    Clin Infect Dis; 2020 Nov; 71(8):e289-e300. PubMed ID: 31784753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-emergence of pneumococcal colonization by vaccine serotype 19F in persons aged ≥5 years after 13-valent pneumococcal conjugate vaccine introduction-Alaska, 2008-2013.
    Gounder PP; Bruden D; Rudolph K; Zulz T; Hurlburt D; Thompson G; Bruce MG; Hennessy TW
    Vaccine; 2018 Jan; 36(5):691-697. PubMed ID: 29279284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.
    van Hoek AJ; Sheppard CL; Andrews NJ; Waight PA; Slack MP; Harrison TG; Ladhani SN; Miller E
    Vaccine; 2014 Jul; 32(34):4349-55. PubMed ID: 24657717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal changes in pneumococcal colonization in a rural African community with high HIV prevalence following routine infant pneumococcal immunization.
    Nzenze SA; Shiri T; Nunes MC; Klugman KP; Kahn K; Twine R; de Gouveia L; von Gottberg A; Madhi SA
    Pediatr Infect Dis J; 2013 Nov; 32(11):1270-8. PubMed ID: 24061271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015.
    Kaur R; Casey JR; Pichichero ME
    Pediatr Infect Dis J; 2016 Aug; 35(8):901-6. PubMed ID: 27420806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharyngeal colonization by Streptococcus pneumoniae in older children and adolescents in a geographical area characterized by relatively limited pneumococcal vaccination coverage.
    Principi N; Terranova L; Zampiero A; Montinaro V; Ierardi V; Peves Rios W; Pelucchi C; Esposito S
    Pediatr Infect Dis J; 2015 Apr; 34(4):426-32. PubMed ID: 25760567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasopharyngeal pneumococcal carriage in healthy Turkish children after 13-valent conjugated pneumococcal vaccine implementation in the national immunization program.
    Kanık Yüksek S; Tezer H; Gülhan B; Özkaya Parlakay A; Güldemir D; Coskun-Ari FF; Bedir Demirdağ T; Kara Uzun A; Kızılgün M; Solmaz S; Kılıç S; Yalınay Çırak M; Baran Aksakal FN
    J Infect Public Health; 2020 Feb; 13(2):266-274. PubMed ID: 31818710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination.
    Heinsbroek E; Tafatatha T; Phiri A; Swarthout TD; Alaerts M; Crampin AC; Chisambo C; Mwiba O; Read JM; French N
    Vaccine; 2018 Nov; 36(48):7369-7376. PubMed ID: 30352744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece.
    Grivea IN; Priftis KN; Giotas A; Kotzia D; Tsantouli AG; Douros K; Michoula AN; Syrogiannopoulos GA
    Vaccine; 2014 Nov; 32(48):6513-20. PubMed ID: 25252194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.